Mary Sheahan
Director/Board Member at CENTOGENE N.V.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peer Schatz | M | 57 | 4 years | |
| Hubert Birner | M | 57 | 7 years | |
| Peter Bauer | M | 54 | 8 years | |
| Guido Prehn | M | 46 | 5 years | |
| Miguel Coego Rios | M | - | 2 years | |
| John Bradshaw | M | 60 |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
| Eric Souêtre | M | 68 | 7 years | |
| Jonathan Sheldon | M | 52 | 4 years | |
| Lennart Streibel | M | - | - | |
| Allison Jeynes-Ellis | M | 58 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 12 years |
| Bettina Goerner | F | - | - | |
| Anna Danilewicz | F | - |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
| Frank Volpers | M | - | 9 years | |
| Daniela Osterholz | F | - | 12 years | |
| Kurt C. Wheeler | M | 71 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
| Ian Rentsch | M | - | 1 years | |
| Ted Love | M | 65 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 11 years |
| Kim Stratton | F | 62 | 3 years | |
| Genghis Lloyd-Harris | M | 67 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | - |
| Anders Gersel Pedersen | M | 73 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 5 years |
| James Reddoch | M | 54 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 10 years |
| David Chiswell | M | 70 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | 5 years |
| Ben Legg | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Berndt A. E. Modig | M | 65 | 5 years | |
| Flemming Ørnskov | M | 66 | 4 years | |
| Holger Friedrich | M | 57 | 6 years | |
| Florian Vogel | M | - | 8 years | |
| Andreas Busch | M | 59 | 1 years | |
| Robert W. de Deugd | M | - | - | |
| Patrice P. Denefle | M | 64 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 21 | 70.00% |
| United Kingdom | 9 | 30.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mary Sheahan
- Personal Network
